Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Sampharindo Perdana is an Indonesian pharmaceutical company headquartered in Semarang, Central Java, that specializes in the manufacturing of generic and over-the-counter (OTC) medicines. As part of the Sampharindo Group, the company operates a production facility certified under Indonesian Good Manufacturing Practices (CPOB) to ensure high-quality standards for its diverse product portfolio. Its offerings include a wide range of therapeutic categories such as analgesics, antipyretics, antitussives, and nutritional supplements. Well-known local brands produced by the company include Samcon, Samcodin, and Samtacid. Sampharindo Perdana is a key player in the Indonesian domestic market, focusing on providing affordable and accessible healthcare solutions through various oral dosage forms including tablets, capsules, and syrups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sampharindo Perdana.